Taiwan Life Science Trend Analysis 2024

While 2023 shows a declining trend in terms of private equity financing of Taiwanese life science companies since 2020, public financing surged year-on-year, raising more than twice as much as in 2022. The three largest private equity financing rounds in 2023 were completed by medical technology companies, led by Syncell, which raised USD 8 million. … Continue reading Taiwan Life Science Trend Analysis 2024

Read more

Canadian Life Science Trend Analysis 2024

In 2023, the Canadian biotech landscape showed stability, largely maintaining the financing levels of the previous year (USD 451 million in 2023 vs. USD 460 million in 2022), but falling short of the record year of 2021. Ontario once again proved to be Canada’s most active province, with the highest number of biotech companies and … Continue reading Canadian Life Science Trend Analysis 2024

Read more

Dutch Life Science Trend Analysis 2024: Market is slowly picking up

Biotechgate, the leading global biotech database, published their annual Trend Analysis Report 2024 of the Dutch life sciences sector in collaboration with hollandbio. In 2022, the Dutch biotech landscape saw a sharp 50% decline in venture financing, reflecting the challenging global economic climate. Fortunately, the tide seems to turn. In 2023, life sciences saw a … Continue reading Dutch Life Science Trend Analysis 2024: Market is slowly picking up

Read more

Maryland Life Science Trend Analysis 2024

Venture financing for Maryland’s life sciences industry in 2023 shows signs of recovery following the significant downturn in 2022, with the total value of private equity financing reaching USD 805m (up from USD 639m in 2022). For the biotech industry, the value of venture financing deals remained stable (USD 453m in 2022 vs. USD 451m … Continue reading Maryland Life Science Trend Analysis 2024

Read more

Norway Life Science Trend Analysis 2023

The Norwegian life sciences industry performed well in 2022 compared to the years before 2021 (2018 – 2020), raising USD 38 million in private equity investments according to Biotechgate data. However, it could not compete with the record level of venture financing in 2021 (USD 65 million). Cytovation ASA secured the largest round in 2022. … Continue reading Norway Life Science Trend Analysis 2023

Read more

Switzerland Life Science Trend Analysis 2023

Although shifts in the geopolitical landscape affected the Swiss life sciences industry in 2022, it resisted a major downturn in terms of private equity funding. Swiss biotech companies raised a total of USD 590 million in venture capital in 36 financing rounds. This is less than in the previous three years, but matches pre-COVID 19 … Continue reading Switzerland Life Science Trend Analysis 2023

Read more

Netherlands Life Science Trend Analysis 2023: A Difficult Year for Venture Financing

Tuesday, 04 July 2023 Biotechgate, the leading global biotech database, published their annual Trend Analysis Report 2023 of the Dutch life sciences sector. In 2022, compared to 2021, venture financing of life science and biotech companies went down by more than 50%. Furthermore, the year-to-year growth rate of new biotech ventures has been decreasing since 2018, with … Continue reading Netherlands Life Science Trend Analysis 2023: A Difficult Year for Venture Financing

Read more

Maryland Life Science Trend Analysis 2023

Maryland’s life science private equity investment landscape in 2022 shifted back to levels seen prior to the exceptional growth experienced in 2021. The total value of life science venture financing in Maryland dropped from USD 1.2 billion in 2021 to half that amount in 2022, with USD 558 million invested. Looking at the top venture … Continue reading Maryland Life Science Trend Analysis 2023

Read more

France Life Science Trend Analysis 2023

The Healthcare Innovation 2023 strategy, launched in 2021 and supported with USD 7.9 billion, aims to establish France as a European leader in the life sciences industry by promoting innovation and growth. One year on, this plan appears to be on track: Despite uncertain market conditions and unlike most other European countries, France was able … Continue reading France Life Science Trend Analysis 2023

Read more

Canada Life Science Trend Analysis 2023

Canadian biotech private equity investment has grown steadily over the past four years, but appears to have hit its peak in 2021 – in 2022, the value of biotech equity financings failed to match the record levels of the previous year (2022: USD 599 million vs. 2021: USD 841 million).  Ontario is Canada’s most active … Continue reading Canada Life Science Trend Analysis 2023

Read more